Rapid Micro Biosystems (RPID) Income towards Parent Company (2020 - 2026)
Rapid Micro Biosystems (RPID) posted Income towards Parent Company of -$14.3 million for Q1 2026, down 14.23% sequentially from -$12.5 million in Q4 2025, and down 26.74% YoY from -$19.5 million in Q1 2025.
Rapid Micro Biosystems (RPID) Income towards Parent Company (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported Income towards Parent Company for 7 years, with the latest figure at -$14.3 million in Q1 2026.
- Quarterly Income towards Parent Company fell 26.74% year-over-year to -$14.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$50.1 million (down 11.83% YoY) and the FY2025 annual result came in at -$47.1 million, changed 0.5% from the prior year.
- Income towards Parent Company eased to -$14.3 million in Q1 2026 per RPID's latest filing, from -$12.5 million in the prior quarter.
- Over five years, Income towards Parent Company peaked at -$9.7 million in Q4 2024 and troughed at -$16.5 million in Q4 2022.
- A 5-year average of -$13.0 million and a median of -$13.1 million in 2022 frame the typical range for Income towards Parent Company.
- The sharpest annual moves came in 2022 and 2025: Income towards Parent Company soared 34.61% in 2022, then slipped 29.29% in 2025.
- Over 5 years, Income towards Parent Company stood at -$16.5 million in 2022, then jumped by 32.14% to -$11.2 million in 2023, then rose by 13.48% to -$9.7 million in 2024, then slipped by 29.29% to -$12.5 million in 2025, then slipped by 14.23% to -$14.3 million in 2026.
- According to Business Quant data, Income towards Parent Company over the past three periods registered -$14.3 million, -$12.5 million, and -$11.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Rapid Micro Biosystems | 80.26 Mn | 60.49 Mn | 1.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.92 Mn |
| Mar 31, 2026 | -14.28 Mn |
| Dec 31, 2025 | -12.50 Mn |
| Sep 30, 2025 | -11.51 Mn |
| Jun 30, 2025 | -11.86 Mn |
| Mar 31, 2025 | -11.26 Mn |
| Dec 31, 2024 | -9.67 Mn |
| Sep 30, 2024 | -11.32 Mn |
| Jun 30, 2024 | -12.58 Mn |
| Mar 31, 2024 | -13.32 Mn |
| Dec 31, 2023 | -11.17 Mn |
| Sep 30, 2023 | -13.39 Mn |
| Jun 30, 2023 | -14.02 Mn |
| Mar 31, 2023 | -13.89 Mn |
| Dec 31, 2022 | -16.46 Mn |
| Sep 30, 2022 | -16.34 Mn |
| Jun 30, 2022 | -13.10 Mn |
| Mar 31, 2022 | -14.93 Mn |
| Dec 31, 2021 | -14.61 Mn |
| Sep 30, 2021 | -24.99 Mn |